Logo image of HBANM

HUNTINGTON BANCSHARES - HBAN 5.7 PERP (HBANM) Stock Fundamental Analysis

NASDAQ:HBANM - Nasdaq - US4461507810

23.26  -0.24 (-1.02%)

Fundamental Rating

2

Taking everything into account, HBANM scores 2 out of 10 in our fundamental rating. HBANM was compared to 405 industry peers in the Banks industry. Both the profitability and financial health of HBANM have multiple concerns. HBANM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HBANM was profitable.
In the past year HBANM had a positive cash flow from operations.
Of the past 5 years HBANM 4 years were profitable.
HBANM had a positive operating cash flow in 4 of the past 5 years.
HBANM Yearly Net Income VS EBIT VS OCF VS FCFHBANM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

1.2 Ratios

HBANM has a Return On Assets (0.76%) which is in line with its industry peers.
HBANM has a Return On Equity of 7.37%. This is comparable to the rest of the industry: HBANM outperforms 43.72% of its industry peers.
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROIC N/A
ROA(3y)0.93%
ROA(5y)0.92%
ROE(3y)9.12%
ROE(5y)8.84%
ROIC(3y)N/A
ROIC(5y)N/A
HBANM Yearly ROA, ROE, ROICHBANM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

HBANM has a Profit Margin (21.22%) which is comparable to the rest of the industry.
HBANM's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for HBANM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 21.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y18.35%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A
HBANM Yearly Profit, Operating, Gross MarginsHBANM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1

2. Health

2.1 Basic Checks

HBANM does not have a ROIC to compare to the WACC, probably because it is not profitable.
HBANM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HBANM Yearly Shares OutstandingHBANM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B
HBANM Yearly Total Debt VS Total AssetsHBANM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B

2.2 Solvency

HBANM has a debt to FCF ratio of 11.20. This is a negative value and a sign of low solvency as HBANM would need 11.20 years to pay back of all of its debts.
HBANM's Debt to FCF ratio of 11.20 is on the low side compared to the rest of the industry. HBANM is outperformed by 73.37% of its industry peers.
HBANM has a Debt/Equity ratio of 0.57. This is a neutral value indicating HBANM is somewhat dependend on debt financing.
HBANM has a worse Debt to Equity ratio (0.57) than 79.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Altman-Z N/A
ROIC/WACCN/A
WACC12.74%
HBANM Yearly LT Debt VS Equity VS FCFHBANM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBANM Yearly Current Assets VS Current LiabilitesHBANM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2

3. Growth

3.1 Past

The earnings per share for HBANM have decreased strongly by -10.71% in the last year.
The Earnings Per Share has been decreasing by -0.32% on average over the past years.
EPS 1Y (TTM)-10.71%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%13.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.63%

3.2 Future

The Earnings Per Share is expected to grow by 6.00% on average over the next years.
The Revenue is expected to grow by 3.94% on average over the next years.
EPS Next Y9.55%
EPS Next 2Y11.32%
EPS Next 3Y2.25%
EPS Next 5Y6%
Revenue Next Year5.81%
Revenue Next 2Y5.33%
Revenue Next 3Y3.33%
Revenue Next 5Y3.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
HBANM Yearly Revenue VS EstimatesHBANM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
HBANM Yearly EPS VS EstimatesHBANM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.61, which indicates a rather expensive current valuation of HBANM.
Based on the Price/Earnings ratio, HBANM is valued a bit more expensive than the industry average as 74.87% of the companies are valued more cheaply.
HBANM is valuated rather cheaply when we compare the Price/Earnings ratio to 27.96, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 16.99, which indicates a correct valuation of HBANM.
Based on the Price/Forward Earnings ratio, HBANM is valued a bit more expensive than the industry average as 72.86% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of HBANM to the average of the S&P500 Index (24.11), we can say HBANM is valued slightly cheaper.
Industry RankSector Rank
PE 18.61
Fwd PE 16.99
HBANM Price Earnings VS Forward Price EarningsHBANM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HBANM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. HBANM is more expensive than 78.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.09
EV/EBITDA N/A
HBANM Per share dataHBANM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HBANM does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.95
PEG (5Y)N/A
EPS Next 2Y11.32%
EPS Next 3Y2.25%

5

5. Dividend

5.1 Amount

HBANM has a Yearly Dividend Yield of 3.68%.
HBANM's Dividend Yield is a higher than the industry average which is at 3.24.
HBANM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

The dividend of HBANM has a limited annual growth rate of 5.35%.
HBANM has been paying a dividend for over 5 years, so it has already some track record.
HBANM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)5.35%
Div Incr Years0
Div Non Decr Years3
HBANM Yearly Dividends per shareHBANM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

68.97% of the earnings are spent on dividend by HBANM. This is not a sustainable payout ratio.
The dividend of HBANM is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP68.97%
EPS Next 2Y11.32%
EPS Next 3Y2.25%
HBANM Yearly Income VS Free CF VS DividendHBANM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B
HBANM Dividend Payout.HBANM Dividend Payout, showing the Payout Ratio.HBANM Dividend Payout.PayoutRetained Earnings

HUNTINGTON BANCSHARES - HBAN 5.7 PERP

NASDAQ:HBANM (1/17/2025, 8:05:33 PM)

23.26

-0.24 (-1.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-17 2025-01-17/bmo
Earnings (Next)N/A N/A
Inst Owners85.57%
Inst Owner ChangeN/A
Ins Owners1.07%
Ins Owner ChangeN/A
Market Cap33.79B
Analysts76.3
Price Target26.62 (14.45%)
Short Float %0%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.72
Dividend Growth(5Y)5.35%
DP68.97%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-14 2025-02-14 (0.35625)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.59%
Min EPS beat(2)4.87%
Max EPS beat(2)8.31%
EPS beat(4)4
Avg EPS beat(4)8.23%
Min EPS beat(4)4.87%
Max EPS beat(4)9.94%
EPS beat(8)8
Avg EPS beat(8)6.22%
EPS beat(12)9
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)2.27%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)-0.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.1%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)4
Avg Revenue beat(16)-0.66%
PT rev (1m)8.89%
PT rev (3m)-6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.45%
EPS NY rev (1m)0%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 18.61
Fwd PE 16.99
P/S 4.72
P/FCF 32.09
P/OCF 27.5
P/B 1.64
P/tB 2.34
EV/EBITDA N/A
EPS(TTM)1.25
EY5.37%
EPS(NY)1.37
Fwd EY5.89%
FCF(TTM)0.72
FCFY3.12%
OCF(TTM)0.85
OCFY3.64%
SpS4.92
BVpS14.18
TBVpS9.92
PEG (NY)1.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.22%
GM N/A
FCFM 14.72%
ROA(3y)0.93%
ROA(5y)0.92%
ROE(3y)9.12%
ROE(5y)8.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y18.35%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Debt/EBITDA N/A
Cap/Depr 24.04%
Cap/Sales 2.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 69.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC12.74%
ROIC/WACCN/A
Cap/Depr(3y)41.64%
Cap/Depr(5y)37.02%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.75%
Profit Quality(3y)158.46%
Profit Quality(5y)150.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.71%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%13.33%
EPS Next Y9.55%
EPS Next 2Y11.32%
EPS Next 3Y2.25%
EPS Next 5Y6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.63%
Revenue Next Year5.81%
Revenue Next 2Y5.33%
Revenue Next 3Y3.33%
Revenue Next 5Y3.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.48%
EBIT Next 3Y10.04%
EBIT Next 5YN/A
FCF growth 1Y-63.84%
FCF growth 3Y27.87%
FCF growth 5Y9.27%
OCF growth 1Y-61.19%
OCF growth 3Y26.17%
OCF growth 5Y9.01%